Animal models of dementia and cognitive dysfunction
Neha1, Rupinder K Sodhi1, Amteshwar S Jaggi1
1Pharmacology Division, Department of Pharmaceutical Sciences and Drug Research, Faculty of Medicine, Punjabi University, Patiala 147002, Punjab, India.
Life Sciences
|July 29, 2014
Summary
This review critically evaluates animal models for dementia and cognitive dysfunction, highlighting their essential role in developing new Alzheimer
Area of Science:
- Neuroscience
- Pharmacology
- Animal models
Background:
- Alzheimer's disease and cognitive deficits stem from complex pathophysiological mechanisms.
- Animal models are crucial for understanding these mechanisms and evaluating potential therapeutics.
Purpose of the Study:
- To provide an exhaustive review of animal models for dementia and cognitive dysfunction.
- To critically evaluate current rodent models and their utility in drug discovery.
- To detail various models representing different pathophysiological stages and causes of dementia.
Main Methods:
- Comprehensive literature review of existing animal models.
- Critical analysis of rodent models for dementia and cognitive impairment.
- Discussion on the application of these models in drug development.
Main Results:
- Identified various animal models that mimic distinct aspects of dementia.
- Evaluated the strengths and limitations of current rodent models.
- Highlighted the importance of model selection for accurate therapeutic evaluation.
Conclusions:
- Animal models are indispensable tools for advancing Alzheimer's disease and dementia research.
- A detailed understanding of diverse models facilitates more effective drug discovery and development.
- Selecting appropriate models is key to understanding dementia's biochemical and behavioral alterations.
More Related Videos
09:45Motor and Hippocampal Dependent Spatial Learning and Reference Memory Assessment in a Transgenic Rat Model of Alzheimer's Disease with Stroke
Published on: March 22, 2016
9.8K
08:01Intracerebroventricular Injection of Amyloid-β Peptides in Normal Mice to Acutely Induce Alzheimer-like Cognitive Deficits
Published on: March 16, 2016
42.4K
Related Concept Videos
01:22Dementia l: Introduction
29
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
29
01:29Alzheimer Disease l: Introduction
19
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
19
01:26Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K
01:30Dementia
685
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
685
01:22Alzheimer's Disease: Treatment
1.3K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.3K